- Home
- ASYS vs ADAG Comparison
ASYS vs ADAG Comparison
Compare ASYS & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASYS
- ADAG
- Stock Information
- Founded
- ASYS 1981
- ADAG 2011
- Country
- ASYS United States
- ADAG China
- Employees
- ASYS N/A
- ADAG N/A
- Industry
- ASYS Industrial Machinery/Components
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- ASYS Technology
- ADAG Health Care
- Exchange
- ASYS Nasdaq
- ADAG Nasdaq
- Market Cap
- ASYS 83.0M
- ADAG 84.8M
- IPO Year
- ASYS N/A
- ADAG 2021
- Fundamental
- Price
- ASYS $7.36
- ADAG $1.84
- Analyst Decision
- ASYS
- ADAG Strong Buy
- Analyst Count
- ASYS 0
- ADAG 4
- Target Price
- ASYS N/A
- ADAG $8.00
- AVG Volume (30 Days)
- ASYS 136.3K
- ADAG 84.8K
- Earning Date
- ASYS 12-03-2025
- ADAG 08-12-2025
- Dividend Yield
- ASYS N/A
- ADAG N/A
- EPS Growth
- ASYS N/A
- ADAG N/A
- EPS
- ASYS N/A
- ADAG N/A
- Revenue
- ASYS $83,634,000.00
- ADAG $103,204.00
- Revenue This Year
- ASYS N/A
- ADAG $7,411.34
- Revenue Next Year
- ASYS $12.93
- ADAG $28.29
- P/E Ratio
- ASYS N/A
- ADAG N/A
- Revenue Growth
- ASYS N/A
- ADAG N/A
- 52 Week Low
- ASYS $3.20
- ADAG $1.30
- 52 Week High
- ASYS $10.80
- ADAG $3.16
- Technical
- Relative Strength Index (RSI)
- ASYS 46.11
- ADAG 52.78
- Support Level
- ASYS $6.75
- ADAG $1.78
- Resistance Level
- ASYS $7.41
- ADAG $1.99
- Average True Range (ATR)
- ASYS 0.41
- ADAG 0.20
- MACD
- ASYS 0.01
- ADAG 0.02
- Stochastic Oscillator
- ASYS 57.61
- ADAG 72.85
About ASYS Amtech Systems Inc.
Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.